Correspondence

Affiliations

Comment

Beatrice Tombolini et al. Retina. 2022.

. 2022 Aug 1;42(8):e38-e39.

doi: 10.1097/IAE.0000000000003553.

¹ Department of Ophthalmology, University Vita-Salute, IRCCS Ospedale San Raffaele, Milan, Italy.

No abstract available

Comment on

CHOROIDAL NEOVASCULARIZATION SECONDARY TO PHOTODYNAMIC THERAPY FOR CENTRAL SEROUS CHORIORETINOPATHY: Incidence, Risk Factors, and Clinical Outcomes.
Hwang S, Noh H, Kang SW, Kang MC, Lee D, Kim SJ. Hwang S, et al. Retina. 2021 Aug 1;41(8):1762-1770. doi: 10.1097/IAE.0000000000003067. Retina. 2021. PMID: 33315827

1. Hwang S, Noh H, Kang SW, et al. Choroidal neovascularization secondary to photodynamic therapy for central serous chorioretinopathy: incidence, Risk Factors, and Clinical Outcomes. Retina 2021;41:1762–1770.
1. Sacconi R, Tomasso L, Corbelli E, et al. Early response to the treatment of choroidal neovascularization complicating central serous chorioretinopathy: a OCT-angiography study. Eye 2019;33:1809–1817.
1. Dansingani KK, Balaratnasingam C, Klufas MA, et al. Optical coherence tomography angiography of shallow irregular pigment epithelial detachments in pachychoroid spectrum disease. Am J Ophthalmol 2015;160:1243–1254.e2.
1. Demirel S, Yanık Ö, Nalcı H, et al. The use of optical coherence tomography angiography in pachychoroid spectrum diseases: a concurrent comparison with dye angiography. Graefe’s Arch Clin Exp Ophthalmol 2017;255:2317–2324.
1. Carnevali A, Capuano V, Sacconi R, et al. OCT angiography of treatment-naïve quiescent choroidal neovascularization in pachychoroid neovasculopathy. Ophthalmol Retin 2017;1:328–332.